Home
Scholarly Works
Asthma exacerbation rate reduction with...
Conference

Asthma exacerbation rate reduction with benralizumab in an integrated analysis of the real-world XALOC-1 study

Authors

Jackson DJ; Pelaia G; Padilla-Galo A; Watt M; Kayaniyil S; Boarino S; Tena JS; Shih VH; Tran TN; Arbetter D

Publisher

European Respiratory Society (ERS)

Publication Date

September 4, 2022

DOI

10.1183/13993003.congress-2022.4592

Name of conference

05.01 - Airway pharmacology and treatment
View published work (Non-McMaster Users)

Contact the Experts team